How Do You Discuss a Research Article in a CRNA Interview?
To discuss a research article in a CRNA interview, explain what the authors asked, what they did and what they found. Then say what makes you cautious about applying the result. Read the full paper. An abstract might tell you the headline, but it won’t prepare you to explain how the finding was produced.
Sachi, CRNA
CRNA

In This Article (7 sections)
A research discussion doesn’t have to become a performance of every statistical term you know. Work toward an explanation you understand well enough to question, including the parts you’ll need to look up.
After reading, practice with the Mock Interview Lab. The seven-day platform trial adds Evidence-Based Practice teaching while you prepare the explanation.
Which article should you choose?
If the program gives you a paper, prepare that one. If it lets you choose, start with a credible article about a clinical or professional question you can explain. Don’t choose the most complicated title to sound impressive.
Who was studied? What was compared? What outcome did the authors measure? You should be able to answer those in ordinary words. Check for corrections, retractions or newer guidance affecting the interpretation too.
Our Evidence-Based Practice lesson separates doing research from using evidence alongside clinical expertise and patient preferences. Keep that in mind when explaining why a paper interests you. Reading one study doesn’t mean its result applies unchanged to every patient.
What should you put on a preparation sheet?
Write the citation and the study’s question. Add the people and setting, study design and any comparison group. Then write the actual result with its numbers and reported uncertainty. Finish with the limitations that affect your interpretation and the question you’d investigate next.
Now close the paper and explain it aloud. Where do you get stuck? Reopen that part instead of memorizing a sentence you don’t understand. The learning library in the trial helps you review evidence concepts before trying again.
How do you explain the numbers accurately?
Start with the study design. An observed association doesn’t prove the exposure caused the outcome. A before-and-after project needs you to consider other changes during that time. Randomization also doesn’t remove the need to check the population, follow-up and limitations.
Let’s break it down with invented numbers. Suppose an event happened in 10 of 100 people in one group and 5 of 100 in another. That’s 10% compared with 5%: a difference of five percentage points. The relative reduction is 50% because you’re comparing the five-point drop with the original 10%.
Those statements describe the same example differently. Say which measure you mean. Use the paper’s own measures and uncertainty, and don’t turn an odds ratio into a risk reduction without the information and method needed.
What does this look like with a real paper?
Now look at a real paper. Use the 2018 SMART trial by Semler and colleagues as a reading exercise:
| What to explain | What the study reports |
|---|---|
| People and setting | 15,802 adults in five ICUs at one academic center. |
| Comparison and design | Balanced crystalloids versus saline. Pragmatic, unblinded, cluster-randomized, multiple-crossover trial; assignment was by ICU and month. |
| Primary outcome | A composite of death, new renal-replacement therapy or persistent renal dysfunction, assessed until hospital discharge or 30 days, whichever came first. |
| Main result | 14.3% versus 15.4% for that composite; conditional odds ratio 0.90, 95% confidence interval 0.82–0.99. |
| Limits to discuss | One center limits how broadly the finding applies. Clinicians weren’t blinded, which could influence decisions to start renal-replacement therapy. |
“Cluster-randomized” means the assignment here happened by ICU and month, rather than separately for each patient. “Composite” means the authors combined the listed outcomes into the main measure. Go back to the methods and results to check how they did that.
The rounded rates differ by 1.1 percentage points. They don’t differ by 11 points. A lower composite result also doesn’t prove every component improved significantly, and the study doesn’t directly compare lactated Ringer’s with Plasma-Lyte.
Practice explaining why the group assignment matters and why you’d inspect each part of the composite. This is a historical trial-reading exercise. Use current evidence and guidance for today’s clinical decisions.
How would you say it in the interview?
Build the answer around the paper you read:
“The authors asked [question] in [population]. They used [design] and measured [outcome]. The main finding was [accurate result]. I found [limitation] relevant because it affects [interpretation or applicability]. The paper made me want to understand [specific follow-up question] before applying the finding to our patients.”
If you don’t know a statistical term, acknowledge the gap instead of inventing a definition. Don’t call a result statistically significant without checking.
Then connect the paper to the patients you know. Does the population resemble them? Does the outcome matter to their care? What else would you need to review? NHLBI’s study-quality assessment guidance gives design-appropriate questions about baseline differences, confounding and bias. Use them to examine the study, not to turn a checklist score into the whole judgment.
Our Final Thoughts
Give yourself time to get through one paper carefully. Explain the question and result without your notes, then return to the part you couldn’t explain. You don’t have to hide a gap in understanding. Use it to choose what to review next before the interview.
Practice discussing the paper you actually read
After reading, use the Mock Interview Lab to practice your explanation. The seven-day platform trial includes evidence and interview teaching for the concepts you want to revisit.


